Background The impact of both COVID‐19 infection and vaccination status on patients with
head and neck squamous cell carcinoma (HNSCC) remains unknown. Objective To …

Background We aimed to study the effect of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infections on patients with head and neck malignancies and evaluate the …

Objective To analyze how the COVID‐19 pandemic has influenced trends in head and neck
squamous cell carcinoma (HNSCC) presentation and diagnosis—including referral patterns …

Objectives During the COVID-19 pandemic, maintenance of safe and timely oncologic care
has been challenging. The goal of this study is to compare presenting symptoms, staging …

Background Pulmonary complications and infections frequently affect patients with head and
neck squamous cell carcinoma (HNSCC). Common characteristics can predispose these …

Objectives This rapid review aims to evaluate the impact of the COVID‐19 pandemic on
incidence of head and neck cancer (HNC) and stage distribution at diagnosis. Design Rapid …

Purpose The healthcare system across the world was forced to implement new policies,
guidelines, and procedures due to the coronavirus disease 2019 (COVID-19) pandemic …

Background The impact of COVID-19 on patients with cancer is emerging, but data are
urgently needed for head and neck cancer (HNC) patients or survivors who are inherently …

Objectives To evaluate the impact of the COVID‐19 lockdown measures on HNC, by
comparing the stage at presentation and treatment of HNC before and after the most severe …

Data sources It is not made clear in this review the different databases selected or how they
conducted their search. The studies used are from 1975-2020 Study selection The authors …